Evidence map›Paper›PMID 38140249›Full record

ArticleVaccines2023

In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics.

Shea K Roe, Brian Felter, Bo Zheng, Sanjay Ram, Lee M Wetzler, Eric Garges, Tianmou Zhu, Caroline A Genco, Paola Massari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. PreclinicalFrontiers in immunology · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shea K RoeDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Brian FelterDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Bo ZhengDivision of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Sanjay RamDivision of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Lee M WetzlerSection of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA.
Eric GargesDepartment of Preventive Medicine and Biostatistics, F. Edward Hebert School of Medicine, Uniformed Services University, Bethesda, MD 20814, USA.
Tianmou ZhuDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Caroline A GencoDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Paola MassariDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.ORCID 0000-0003-3106-0711
Tufts University · USUniversity of Massachusetts Chan Medical School · USBoston University · USUniformed Services University of the Health Sciences · US

Funding

Novel vaccine antigens against N. gonorrhoeaeR01AI166537 · NIAID · TUFTS UNIVERSITY BOSTON · PI Paola Massari · 2022 to 2026
$2.2M
NIAID NIH HHS R01 AI166537NIH HHS 1R01AI166537-01
6 · The paper itself

Abstract

Gonorrhea, a sexually transmitted disease caused by

Indexed as

adjuvantsbactericidal antibodiesgonorrheaTh1/Th2 responsesvaccine

Identifiers

PMID38140249
PMCPMC10747275
OpenAlexW4389686143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.